New York 2025-2026 Regular Session

New York Assembly Bill A07869

Introduced
4/11/25  

Caption

Authorizes prescription labels to include symptom or purpose for which the drug is being prescribed if the patient requests from their health care provider that such information be disclosed on the label, with exceptions.

Companion Bills

No companion bills found.

Previously Filed As

NY S09945

Permits prescription labels for medication abortion prescription drugs to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

NY A00084

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY S08694

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY A04494

Provides that every insurance policy which provides coverage for prescription drugs shall insure that there is continuous coverage of a single source drug that is part of a prescribed therapy until such prescribed therapy is no longer medically necessary for the enrollee of such policy; defines "single source drug".

NY S07344

Provides that every insurance policy which provides coverage for prescription drugs shall insure that there is continuous coverage of a single source drug that is part of a prescribed therapy until such prescribed therapy is no longer medically necessary for the enrollee of such policy; defines "single source drug".

NY A03374

Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.

NY S05704

Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.

NY S02310

Provides for the proper packaging and labeling of pharmaceutical drugs; creates penalties for intentional fraudulent replacement, packaging, and labeling of such drugs; provides for better consumer protection.

NY A10479

Enacts the "foreign drug transparency act"; requires the disclosure to a health plan, pharmacy and patient whether a prescription drug was manufactured or compounded in a foreign country; whether the prescription was approved by the federal food and drug administration foreign drug inspection program; requires the date of the last inspection of such prescription drug by the federal food and drug administration foreign drug inspection program; requires certain labelling on such drugs.

NY A09951

Requires food products using ingredients classified as major food allergens to be labelled or branded as such; requires food sellers to provide written notice to stores for food labels containing new ingredients classified as major food allergens; requires such foods are labeled or branded as such by a food seller until such food has appropriately labeled packaging.

Similar Bills

No similar bills found.